Status:
RECRUITING
Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Agence régionale de santé Ile de France
Institut de Recherche en Santé Publique, France
Conditions:
Healthcare Providers
Postpartum
Eligibility:
All Genders
18+ years
Brief Summary
The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made po...
Detailed Description
The aim of this project is to highlight whether dedicated funding for vaccine procurement in healthcare institutions can generate both individual and collective benefits in terms of improved vaccinati...
Eligibility Criteria
Inclusion Criteria:
For patients:
-
For the assessment of pneumococcal coverage among patients eligible for this vaccination:
- Individuals aged 18 years or older,
- Individuals followed in outpatient consultations within a department and healthcare institution participating in the project;
- Individuals eligible for pneumococcal vaccination against according to current French recommendations,
- Individuals meeting the eligibility conditions and receiving care under long-term illness coverage (ALD) or benefiting from complementary universal health coverage (C2S) or state medical aid (AME).
-
For the assessment of pertussis vaccination among pregnant women:
- Women aged 18 years or older,
- Women who have had at least one follow-up outpatient consultation from 20 weeks of gestation in a maternity ward participating in the project,
- Women in the immediate postpartum period (during their maternity stay) who have given birth to one or more live children and delivered after 36 weeks of gestation,
- Women who have declared their pregnancy and are covered under maternity insurance (i.e., from the first day of the sixth month of pregnancy until the 12th day after delivery).
For healthcare professionals: all vaccinating healthcare providers working in a participating department or center.
Exclusion Criteria:
- Individuals seen in settings other than outpatient consultations (day hospital, week hospital, conventional hospitalization, International Vaccination Center).
Key Trial Info
Start Date :
November 19 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
2920 Patients enrolled
Trial Details
Trial ID
NCT07243236
Start Date
November 19 2025
End Date
July 1 2027
Last Update
April 8 2026
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
COCHIN HOSPITAL - Assistance Publique-Hôpitaux de Paris (APHP)
Paris, IDF, France, 75014
2
Sud Seine Et Marne Hospital
Fontainebleau, France, 77300
3
Sud Seine Et Marne Hospital
Montereau-Fault-Yonne, France, 77130
4
Sud Seine Et Marne Hospital
Nemours, France, 77140